Last updated 2026-07-26
- Raised $16M Series A led by Marius Nacht, Apr 2022
- Raised $1.1M grant, Apr 2019
- Raised $1M Seed round, Oct 2009
Total raised
$18.4M
Last: Undisclosed Round 2022-05
Stage
Seed
Founded
2008
Headcount
13
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
BioGenCell is an Israeli biotechnology company dedicated to transforming the lives of patients with degenerative microvascular diseases through advanced personalized cell therapy treatments. The company's proprietary TRACT (Tissue Regenerative Activated Cell Therapy) technology uses a patient's own white blood cells to create a unique mixture of therapeutic cells that regenerate blood vessels, reduce inflammation, and promote tissue regeneration and healing. BioGenCell's lead product, BGC101, is currently in Phase 2/3 clinical trials for the treatment of severe limb-threatening ischemia (CLI) and chronic limb-threatening ischemia (CLTI).
Funding history · 4 rounds · $18.4M total
2022-04
A Round
$16.0M
★ Marius Nacht
2019-04
Grant
$1.1M
2009-10
Seed
$1.0M
1969-12
Grant
$250K
Headcount over time
From 6 (2020-12) to 13 (2026-07) · +7 (+117%) · 20 points · source: Finder history + radar grounding
Q&A
- What is BioGenCell's primary focus?
- BioGenCell is an Israeli biotechnology company focused on developing personalized cell therapy treatments for degenerative microvascular diseases using a patient's own white blood cells.
- What is BioGenCell's lead product and its current clinical trial status?
- BioGenCell's lead product, BGC101, is currently in Phase 2/3 clinical trials for the treatment of severe limb-threatening ischemia (CLI) and chronic limb-threatening ischemia (CLTI).
- When did BioGenCell receive FDA Fast Track designation for BGC101?
- In December 2024, BioGenCell received FDA Fast Track designation with expanded access for BGC101.
- Who led BioGenCell's $16 million Seed round in May 2022?
- BioGenCell raised a $16 million Seed round in May 2022, led by Marius Nacht.
- What is BioGenCell's proprietary technology called?
- BioGenCell's proprietary technology is called TRACT (Tissue Regenerative Activated Cell Therapy).
- How many employees does BioGenCell currently have?
- BioGenCell has 13 employees, falling within the 11-50 employee bucket.
- What is the total amount of funding BioGenCell has raised to date?
- BioGenCell has raised a total of $18.6 million USD.
- When was BioGenCell founded?
- BioGenCell was founded in 2008.
Team · 3
Yael Porat
Founder · Founder, CEO & CSTO
Eyal Peleg
Founder · Founder & CFO
Michael Belkin
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLaboratoriesLife SciencesBiotechnology
Business model
B2B
Highlights
1 PatentsVerified
Tags
degenerative-diseasesstem-cellshospitalsdiabetestherapeuticscell-therapymedical-technologiesbiotechnologypersonalized-medicineclinicsdoctorshealthcare-providerscardiovascularimmunologyoncologyregenerative-medicinestrokecancertreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | biogencell.net |
|---|---|
| linkedin.com/company/69232576 | |
| facebook.com/www.BioGenCell.net |
Identifiers & details
| Legal name | Biogencell Ltd. |
|---|---|
| Founded | 2008 |
| Employees (exact) | 13 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
Web history (Wayback)
| Domain | biogencell.net |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514215250 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-12-23 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 2 |
| Registry events | 3 — charge (2), people (1) |
| Registered address | דברי חיים 16 נתניה |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-10 | רישום שעבוד |
| 2025-08-10 | רישום שעבוד |
| 2026-02-08 | עדכון דירקטורים-הסרת דירקטור |